Wednesday, April 21, 2021
Home Latest Pharma-News

Latest Pharma-News

Sanofi continues to strengthen its vaccines manufacturing capacities in Singapore

April 12 2021: Sanofi announced a €400 million investment over five years to create a unique vaccine production center in Singapore, pushing...

AZ’s Update on the DARE-19 Phase III trial for Farxiga in COVID-19

April 12, 2021: "AstraZeneca and Saint Luke’s Mid America Heart Institute today announced high-level results of the primary analysis from the DARE-19...

FDA Authorizes Device that Uses AI to Detect Potential Signs of Colon Cancer

April 09, 2021: "The U.S. FDA authorized marketing of the GI Genius, the first device that uses artificial intelligence (AI) based on...

Lilly and Incyte announce results from baricitinib’s COV-BARRIER study in hospitalized COVID-19 patients

April 8, 2021: Eli Lilly and Company and Incyte announced results of COV-BARRIER, a Phase 3 study evaluating baricitinib 4 mg once daily...

BMS Announces Opdivo plus Yervoy in Esophageal Squamous Cell Carcinoma

April 8, 2021: "Bristol Myers Squibb announced positive topline results from the Phase 3 CheckMate -648 trial evaluating treatment with Opdivo (nivolumab)plus chemotherapy or Opdivo plus Yervoy (ipilimumab) in...

FDA Releases Action Plan for Reducing Exposure to Toxic Elements from Foods for Babies

April 08, 2021: "Protecting one of our most vulnerable populations, babies and young children, is among the U.S. Food and Drug Administration’s...

Sanofi completes Kymab acquisition

April 09 2021: "Sanofi announced today the successful completion of its acquisition of Kymab Group Ltd., adding KY1005 to its pipeline, a fully human...

Interim late-breaking clinical data validate not-alpha profile of THOR-707, Sanofi’s novel investigational IL-2

 April 9, 2021: "Interim data from a first-in-human trial evaluating the safety, therapeutic activity and maximum tolerable dose of THOR-707 (SAR444245), a...

CDC Awards $3 Billion to Expand COVID-19 Vaccine Programs

April 6, 2021: The Centers for Disease Control and Prevention (CDC) has awarded funding to support local efforts to increase vaccine uptake...

Artios Pharma and Novartis to Create Next Generation DDR Cancer Therapies

April 7, 2021: "Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company exploiting synthetic lethality to develop a broad pipeline of...

FDA Issues Emergency Use Authorization for the Symbiotica COVID-19 Self-Collected Antibody Test System

April 06, 2021: The U.S. Food and Drug Administration announced it has issued an emergency use authorization (EUA) for the Symbiotica COVID-19 Self-Collected Antibody...

New study suggests vegan diet could control blood sugar for people with, or at risk of, type 2 diabetes

April 06, 2021: "A study into the effects of a vegan diet in people with or at risk of developing type 2...

Most Read

Chemotherapy-free treatment option to be offered to patients with England’s most common leukaemia

April 21, 2021: A brand new oral treatment for an incurable blood cancer has been recommended for NHS use by NICE.

GW Pharma receives EU approval for EPIDYOLEX® for treatment of seizures

April 20, 2021: "GW Pharmaceuticals, a world leader in discovering, developing and delivering regulatory approved cannabis-based medicinesannounces that the European Commission has...

Amgen Successfully Completes Acquisition Of Five Prime Therapeutics

April 16, 2021: "Amgen announced that it has successfully completed its previously announced tender offer to purchase all outstanding shares of...

JCVI issues new advice on COVID-19 vaccination for pregnant women

April 16, 2021: There have been no specific safety concerns identified with any brand of coronavirus (COVID-19) vaccines in relation to pregnancy.